Roivant Sciences Ltd. buy BiotechBee
Start price
24.06.23
/
60%
€9.00
Target price
31.12.25
€16.00
Performance (%)
25.44%
End price
14.12.24
€11.29
Summary
This prediction ended on 14.12.24 with a price of €11.29. The BUY prediction by BiotechBee finished with a performance of 25.44%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Roivant Sciences Ltd. | - | - | - |
| iShares Core DAX® | -1,10 % | -6,08 % | 3,20 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % | 20,24 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % | 27,55 % |
| iShares S&P 500 | -0,06 % | 0,88 % | 14,89 % |
According to BiotechBee what are the pros and cons of Roivant Sciences Ltd. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Roivant Sciences Ltd. diskutieren
Buy mit Kursziel 16,0
In the thread Trading Roivant Sciences Ltd.
Buy beendet

